MR Imaging-Based Volumetry in Patients with Early-Treated Phenylketonuria

References

1. ↵
   Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic basis of inherited disease. Vol 1. 17th ed. New York, NY: McGraw-Hill;1995:1015–1075
2. ↵
   Brenton DP, Pietz J. Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 2000;159 (suppl 2):S114–S120
3. ↵
   Magnotta VA, Harris G, Andreasen NC, et al. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 2002;26:251–264

   CrossRefPubMedWeb of Science
4. ↵
   Harris G, Andreasen NC, Cizadlo T, et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr 1999;23:144–154

   CrossRefPubMedWeb of Science
5. ↵
   Pantel J, O’Leary DS, Cretsinger K, et al. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus 2000;10:752–758

   CrossRefPubMedWeb of Science
6. ↵
   Magnotta VA, Heckel D, Andreasen NC, et al. Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology 1999;211:781–790

   PubMedWeb of Science
7. ↵
   Spinks R, Magnotta VA, Andreasen NC, et al. Manual and automated measurement of the whole thalamus and mediodorsal nucleus using magnetic resonance imaging. Neuroimage 2002;17:631–642

   CrossRefPubMed
8. ↵
   Mitchell TN, Free SL, Merschhemke M, et al. Reliable callosal measurement: population normative data confirm sex-related differences. AJNR Am J Neuroradiol 2003;24:410–418

   Abstract/FREE Full Text
9. ↵
   Mohr A, Knauth M, Weisbrod M, et al. [Similarity of the brains of twins]. Rofo 2001;173:515–521

   PubMed
10. Okugawa G, Takase K, Nobuhara K, et al. Inter- and intraoperator reliability of brain tissue measures using magnetic resonance imaging. Eur Arch Psychiatry Clin Neurosci 2003;253:301–306

    CrossRefPubMed
11. Hsu YY, Schuff N, Du AT, et al. Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging 2002;16:305–310

    CrossRefPubMedWeb of Science
12. ↵
    Schnack HG, van Haren NE, Hulshoff Pol HE, et al. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp 2004;22:312–320

    CrossRefPubMedWeb of Science
13. ↵
    Dyer CA. Comments on the neuropathology of phenylketonuria. Eur J Pediatr 2000;159(suppl 2):S107–S108
14. ↵
    Huttenlocher PR. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 2000;159 (suppl 2):S102–S106
15. ↵
    Dyer CA, Kendler A, Philibotte T, et al. Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol 1996;55:795–814

    CrossRefPubMed
16. ↵
    Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679–688

    CrossRefPubMed
17. ↵
    Ullrich K, Moller H, Weglage J, et al. White matter abnormalities in phenylketonuria: results of magnetic resonance measurements. Acta Paediatr Suppl 1994;407:78–82

    PubMed
18. ↵
    Thompson AJ, Tillotson S, Smith I, et al. Brain MRI changes in phenylketonuria: associations with dietary status. Brain 1993;116:811–821

    Abstract/FREE Full Text
19. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 1994;344:87–90

    CrossRefPubMedWeb of Science
20. ↵
    Pearsen KD, Gean-Marton AD, Levy HL, Davis KR. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 1990;177:437–440

    PubMedWeb of Science
21. ↵
    Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis 2002;13 Suppl 2:53–57
22. ↵
    Pietz J, Kreis R, Schmidt H, et al. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 1996;201:413–420

    PubMedWeb of Science
23. ↵
    Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995;127:251–255

    CrossRefPubMedWeb of Science
24. ↵
    Brenton DP, Tarn AC, Cabrera-Abreu JC, Lilburn M. Phenylketonuria: treatment in adolescence and adult life. Eur J Pediatr 1996;155 (suppl 1):S93–S96
25. ↵
    Hanley WB, Feigenbaum AS, Clarke JT, et al. Vitamin B₁₂ deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr 1996;155 (suppl 1):S145–S147
26. Villasana D, Butler IJ, Williams JC, Roongta SM. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 1989;12:451–457

    CrossRefPubMed
27. ↵
    Leuzzi V, Trasimeni G, Gualdi GF, Antonozzi I. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients. J Inherit Metab Dis 1995;18:624–634

    CrossRefPubMedWeb of Science
28. ↵
    Rupp A, Kreis R, Zschocke J, et al. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. J Cereb Blood Flow Metab 2001;21:276–284

    CrossRefPubMedWeb of Science
29. ↵
    Pietz J, Rupp A, Burgard P, et al. No evidence for individual blood-brain barrier phenylalanine transport to influence clinical outcome in typical phenylketonuria patients. Ann Neurol 2002;52:382–383; reply 383–384

    PubMed
30. ↵
    Koch R, Moats R, Guttler F, et al. Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 2000;106:1093–1096

    Abstract/FREE Full Text
31. ↵
    Weglage J, Wiedermann D, Denecke J, et al. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol 2001;50:463–467

    CrossRefPubMedWeb of Science
32. ↵
    Smith I, Beasley MG, Ades AE. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 1991;66:311–316

    Abstract/FREE Full Text
33. ↵
    Swayze VW 2nd, Andersen AE, Andreasen NC, et al. Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord 2003;33:33–44

    CrossRefPubMedWeb of Science
34. ↵
    Arnold GL, Vladutiu CJ, Kirby RS, et al. Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 2002;141:243–246

    CrossRefPubMedWeb of Science